Follow Up Interview with The American Macular Degeneration Foundation (AMDF)

Questions and answers with AMDF.

Interview for Rare Patient Voice

Providing patients and caregivers an opportunity to participate in research.

Unveiling Progress: NeuroSolv Therapeutics’ Path to Advancing Spinal Cord Injury Treatment

The evolution of spinal cord injury treatments through groundbreaking science.

Industry Partner Foundation for the National Institutes of Health

Questions and answers with the Foundation for the National Institutes of Health (FNIH).

AscellaHealth Q&A with Charlene Son Rigby

Insight into Global Genes from the new CEO.

Decentralized Trials & Research Alliance

Interview questions and answers for the Decentralized Trials & Research Alliance (DTRA).

Rare & Undiagnosed Network Provides Advocacy, Networking and Support for Patients and Families

Increasing support and awareness worldwide for rare and undiagnosed patients and families.

Honor Friends, Family and All People with Rare Diseases: February 28, 2023 is Rare Disease Day

An annual event to help raise awareness of rare disease patients

Supporting Individuals and Families with Information and Resources for Managing Hemophilia

Addressing debilitating issues and expensive treatments for Hemophilia

Optime Care Partners with Pharmaceutical Manufacturers to Deliver a Full Suite of Integrated Pre-Commercialization, Patient Management and HUB Services

Enhanced Partnership with Rigel Pharmaceuticals, Inc. for Rezlidhia™ Patients.

Reflecting on National Family Caregivers Month

Honoring caregivers across the nation who provide essential care for rare disease patients.

American Pharmacists Month - Recognizing Optime Care’s Brandon Salke, Pharm.D., and All Pharmacists Serving the Nation’s Rare Disease Patients

Recognizing specialty pharmacists for their work supporting the rare disease community.

Helping Pharmaceutical Companies Reach and Empower Rare Disease Patients

From Clinical Trials and Pre-Commercialization, to Launch

Optime Care & National Association of Specialty Pharmacy Collaboration

Podcast Series Maps Patient Journey Across Specialty Pharmacy and Healthcare

Pharmaceutical Drug Launches

AscellaHealth Family of Companies -- Including Subsidiary Optime Care -- Brings Integrated, Customized Approach for Specialty Drugs, Underscores Value of Effective Launch Strategies

Customized Market Access is the Better Approach for Rare Disease/Orphan Drugs

The growth of the rare disease therapeutics market and orphan drugs.

Sickle Cell Disease Association of America/Philadelphia/Delaware Valley Chapter Improves the patient journey for individuals with sickle cell disease

A group of disorders that cause red blood cells to become misshapen and break down.

Dedicated Care Coordinators Improve Diagnostic Journey, Foster Market Access, Enhance Patient Experience

Disease management program that features a dedicated team of patient care coordinators for patients with undiagnosed medical condition or rare diseases.

Specialty Pharmacists Employ Patient-First Strategy to Optimize Patient Journey and Outcomes

Optime Care’s specialty pharmacists serve as a critical part of effective care management.

OPTIME CARE CORNER: Patient-First Approach Provides Optimal Clinical Outcomes

Optime Care’s specialty pharmacists help rare disease patients overcome key barriers to effective treatments.

Location Matters: Optimizing Site of Care for Infusion Therapy

Site of Care (SOC) Optimization is a top proven strategy.

AscellaHealth Awards Walmart Preferred Status for Home Infusion Pharmacy Network

AscellaHealth is pleased to announce that we have chosen Walmart as one of our pharmacies for preferred status within our Home Infusion Pharmacy Network

AscellaHealth Forges Strategic Alliance with Optime Care: Expands Portfolio of Innovative Services for Specialty Pharmacy Industry

AscellaHealth Forges Strategic Alliance with Optime Care: Expands Innovative Services for Specialty Pharmacy and Enhances Focus on Rare Diseases